Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up study

Colorectal cancer is a serious cancer with high mortality. Most of the recurrence usually occurred within two years after surgery. This study was conducted in Nineveh Medical Center and Al-Jammhorri Hospital to evaluate colorectal cancer patients in a follow up study for two years. Serum carcino...

Full description

Bibliographic Details
Main Authors: Taha HT Al-Saigh, Shatha A Abdulmawjood, Faris A Ahmed
Format: Article
Language:English
Published: College of Pharmacy / Mustansiriyah University 2022-04-01
Series:Al-Mustansiriyah Journal of Pharmaceutical Sciences
Online Access:https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/791
_version_ 1797223924719681536
author Taha HT Al-Saigh
Shatha A Abdulmawjood
Faris A Ahmed
author_facet Taha HT Al-Saigh
Shatha A Abdulmawjood
Faris A Ahmed
author_sort Taha HT Al-Saigh
collection DOAJ
description Colorectal cancer is a serious cancer with high mortality. Most of the recurrence usually occurred within two years after surgery. This study was conducted in Nineveh Medical Center and Al-Jammhorri Hospital to evaluate colorectal cancer patients in a follow up study for two years. Serum carcinoembryonic antigen, colonoscopy, ultrasound of the abdomen, and chest X rays were used for evaluation. One hundred and ninety-four patients with colorectal cancer were included in the study. The patients were diagnosed colorectal adenocarcinomas by histopathology and staged according to Duke’s classification. The patients were undergone surgical removal of the cancer. Chemotherapy was started to the patient after two weeks of the surgery. Blood samples were taken one week before and one week after surgery. Other blood samples were taken after chemotherapy and then every six months for two years. The blood samples were analyzed for serum carcinoembryonic antigen. The patients were also checked by colonoscopy, ultrasound for abdomen, and chest X ray every six months. Serum carcinoembryonic antigen in colorectal patients was higher than 5 ng/mL and decreased significantly after surgery but still higher than 5 ng/mL. After chemotherapy serum decreased significantly compared with that after surgery. During the two-year period serum carcinoembryonic antigen was not significantly different from that in patients after chemotherapy. Twenty-one patients died after two years of the study Serum carcinoembryonic antigen in the dead patients was much significantly higher than 5 ng/mL before surgery and decreased significantly after operation and after chemotherapy but still higher than 5 ng/mL. In conclusion, colorectal cancer is a significant disease in Iraq. The mortality rate is high due to lack of education of the community to that disease. Carcinoembryonic antigen marker is still acceptable test but should be used with other clinical assessments
first_indexed 2024-04-24T13:44:57Z
format Article
id doaj.art-609378230fe84287b8192dcb2d8a70b4
institution Directory Open Access Journal
issn 1815-0993
2959-183X
language English
last_indexed 2024-04-24T13:44:57Z
publishDate 2022-04-01
publisher College of Pharmacy / Mustansiriyah University
record_format Article
series Al-Mustansiriyah Journal of Pharmaceutical Sciences
spelling doaj.art-609378230fe84287b8192dcb2d8a70b42024-04-04T06:56:30ZengCollege of Pharmacy / Mustansiriyah UniversityAl-Mustansiriyah Journal of Pharmaceutical Sciences1815-09932959-183X2022-04-0121310.32947/ajps.v21i3.791Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up studyTaha HT Al-Saigh0Shatha A Abdulmawjood1Faris A Ahmed2Ninevah College of Medicine, University of Nineveh, MosulNinevah College of Medicine, University of Nineveh, MosulCollege of Pharmacy, University of Uruk, Baghdad Colorectal cancer is a serious cancer with high mortality. Most of the recurrence usually occurred within two years after surgery. This study was conducted in Nineveh Medical Center and Al-Jammhorri Hospital to evaluate colorectal cancer patients in a follow up study for two years. Serum carcinoembryonic antigen, colonoscopy, ultrasound of the abdomen, and chest X rays were used for evaluation. One hundred and ninety-four patients with colorectal cancer were included in the study. The patients were diagnosed colorectal adenocarcinomas by histopathology and staged according to Duke’s classification. The patients were undergone surgical removal of the cancer. Chemotherapy was started to the patient after two weeks of the surgery. Blood samples were taken one week before and one week after surgery. Other blood samples were taken after chemotherapy and then every six months for two years. The blood samples were analyzed for serum carcinoembryonic antigen. The patients were also checked by colonoscopy, ultrasound for abdomen, and chest X ray every six months. Serum carcinoembryonic antigen in colorectal patients was higher than 5 ng/mL and decreased significantly after surgery but still higher than 5 ng/mL. After chemotherapy serum decreased significantly compared with that after surgery. During the two-year period serum carcinoembryonic antigen was not significantly different from that in patients after chemotherapy. Twenty-one patients died after two years of the study Serum carcinoembryonic antigen in the dead patients was much significantly higher than 5 ng/mL before surgery and decreased significantly after operation and after chemotherapy but still higher than 5 ng/mL. In conclusion, colorectal cancer is a significant disease in Iraq. The mortality rate is high due to lack of education of the community to that disease. Carcinoembryonic antigen marker is still acceptable test but should be used with other clinical assessments https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/791
spellingShingle Taha HT Al-Saigh
Shatha A Abdulmawjood
Faris A Ahmed
Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up study
Al-Mustansiriyah Journal of Pharmaceutical Sciences
title Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up study
title_full Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up study
title_fullStr Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up study
title_full_unstemmed Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up study
title_short Prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients: a follow up study
title_sort prognostic factor of serum carcinoembryonic antigen in colorectal cancer patients a follow up study
url https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/791
work_keys_str_mv AT tahahtalsaigh prognosticfactorofserumcarcinoembryonicantigenincolorectalcancerpatientsafollowupstudy
AT shathaaabdulmawjood prognosticfactorofserumcarcinoembryonicantigenincolorectalcancerpatientsafollowupstudy
AT farisaahmed prognosticfactorofserumcarcinoembryonicantigenincolorectalcancerpatientsafollowupstudy